Most European stock markets continued with small losses in Wednesday’s trading, with investors appearing reluctant to continue yesterday’s rally despite the positive developments regarding the new coroner Omicron.
European indices and Wall Street closed with strong gains on Tuesday, drawing impetus from the reassuring statements of top health experts and pharmaceutical executives about the Omicron mutation. Leading US epidemiologist Anthony Fauci told AFP yesterday that it was “almost certain” that the Omicron variant did not cause more serious illness than Delta. Meanwhile, Pfizer CEO Albert Burla said on Tuesday that Omicron appeared to be milder than previous mutations.
The CEO of Pfizer returned today, announcing that the existing vaccine is effective against mutation in three doses.
In particular, Pfizer and BioNTech announced today that their results in an “initial laboratory study” showed that their COVID-19 vaccine neutralized the micron mutation of the coronavirus after three or two doses and the booster.
“While both doses of the vaccine continue to provide protection against severe disease from the micron strain, it is clear from these preliminary data that protection is improved by a third dose of the vaccine,” said Pfizer CEO Albert Burla.
The two companies also estimated that they will be able to have ready for delivery a version of their vaccine for the micron mutation by March 2022.
On the dashboard, the pan-European STOXX 600 recorded small losses of 0.1% at 479.72 points,
The German DAX lost 0.45% at 15,742.89 points, the French CAC 40 recorded small losses of 0.1% at 7,057.66 points, while the British FTSE 100 index gained 0.2% at 7,357.57 points.
In the periphery, the Italian FTSE MIB lost 0.6%, while the Spanish IBEX 35 fell 0.5%.
.
I am Sophia william, author of World Stock Market. I have a degree in journalism from the University of Missouri and I have worked as a reporter for several news websites. I have a passion for writing and informing people about the latest news and events happening in the world. I strive to be accurate and unbiased in my reporting, and I hope to provide readers with valuable information that they can use to make informed decisions.
